Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03886662
Title A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lixte Biotechnology Holdings, Inc.
Indications

myelodysplastic syndrome

myelodysplastic/myeloproliferative neoplasm

Therapies

LB-100

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.